| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.04 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |